Trial Profile
Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Jun 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Metformin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms XBD
- 14 Jun 2017 New trial record